The Latest Breaking News from Eli Lilly

As global medical needs and technology evolve, the pharmaceutical industry is expected to thrive. Therefore, fundamentally strong pharma stocks Eli Lilly (LLY), AstraZeneca (AZN) and GSK (GSK) might be ideal additions to your portfolio. Read on.

Investors put a lot of attention on Nvidia and the rest of the Magnificent Seven. But two of these giants aren't nearly as fabulous.

The pharma industry's potential for sustained growth is reinforced by an aging population, escalating healthcare demands, and the increase in chronic diseases. Therefore, let’s assess the fundamentals of pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Abbvie (ABBV) to determine the most promising choice for the current year….

Apple and Microsoft are battling it out to be the most valuable in the S&P 500. But analysts already predict who will be the winner.

The S&P 500 rebounded last week near record highs, but is up just 0.2% so far in 2024. These are the index's top performers so far.

Just when it looked like technology stocks took over the S&P 500 — another sector is on the rise.

Eli Lilly (LLY) is showing elevated implied volatility with an IV Percentile of 98%, and that could mean it’s a good time for an iron condor trade.

As biotech stocks boom on a strong 2024 outlook following a rough two years, the XBI ETF launches a fresh breakout.

Alphabet unit Isomorphic Labs, which uses AI to help discover new drugs, entered collaboration deals with Eli Lilly and Novartis.